Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFEPIME vs CEFIDEROCOL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFEPIME vs CEFIDEROCOL: Safety Overview

Metric CEFEPIME CEFIDEROCOL
Total FAERS Reports 5,540 649
Deaths Reported 997 359
Death Rate 18.0% 55.3%
Hospitalizations 3,055 134
Average Patient Age 56.5 yrs 57.0 yrs
% Female Patients 47.6% 37.9%
FDA Approval Date Aug 21, 2018 Nov 14, 2019
Manufacturer Apotex Corp. Shionogi Inc.
Route INTRAMUSCULAR INTRAVENOUS
Marketing Status Discontinued Prescription